Search

everythinglearnresearchcommunity

for

Search:↓

A man with vitiligo and alopecia saw quick skin and hair improvement with ruxolitinib, but skin color gains were lost after stopping treatment.

Ritlecitinib may cause serious side effects like blood clots in alopecia areata patients.

Kevis P.F. may help with hair care when used with other products.

Upadacitinib significantly improved a man's severe scalp condition when other treatments failed.

The document concludes that side effects from Smoothened inhibitor drugs for skin cancer are reversible and can be managed with a team approach to maintain quality of life.

Certain peptides can prevent hair loss in young rats caused by a cancer drug.

Upadacitinib successfully treated a child's severe skin and hair loss issues.

Tofacitinib regrew hair in a man with total hair loss but raised cytokine levels, needing more research on possible side effects.

Finasteride may improve prostate cancer therapy by enhancing testosterone's benefits and reducing risks.

Patients on dabrafenib and trametinib for melanoma often experience skin side effects.

Upadacitinib is effective and safe for treating severe alopecia areata in teens.

The trial showed that a new under-the-tongue treatment for severe hair loss was somewhat effective in a small group of people.

The treatment was effective for advanced non-Hodgkin's lymphomas.

Abrocitinib effectively treated severe atopic dermatitis and mild alopecia areata in a 12-year-old boy after dupilumab failed.

CI-1033 causes skin lesions in rats, similar to humans, due to EGF receptor inhibition.

CEFFE injections effectively and safely improve postinflammatory hyperpigmentation.

Two drugs, ritlecitinib and brepocitinib, improved scalp hair loss condition markers.

New treatments for cancer and skin disorders show promise in disrupting harmful cell interactions and promoting hair growth.

Ivarmacitinib effectively regrows hair in severe alopecia areata.

The study created special nanoparticles that effectively deliver an anti-inflammatory drug to treat skin inflammation in psoriasis.

Combining flutamide and finasteride can reduce prostate weight and tumor growth, potentially benefiting treatments needing optimal DHT inhibition.

Ritlecitinib is a new treatment for severe hair loss in people 12 and older.

Compounds from Pterocarpus indicus may help treat benign prostatic hyperplasia by stopping cell growth.

EGFR cancer drugs often cause a rash, which can lead to distress and isolation, but may also improve outcomes for some cancer patients. Current treatments for the rash are limited, but a compound called menadione shows promise.

New hybrid compound found to effectively prevent hair loss.

Budesonide and N-acetylcysteine reduced tumors and alopecia in mice, regardless of FHIT gene status.

Excessive eyelash growth from erlotinib may indicate positive tumor response and help treat madarosis.

Upadacitinib and narrowband UVB effectively treated a child's vitiligo and alopecia areata.